Virtus LifeSci Biotech Clinical Trials ETF (BBC)Health | Exchange Traded Fund | NYSEArca
51.34 USD
-1.82
(-3.432%) ⇩
(July 13, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 4:30 a.m. EDT
The immediate outlook is strongly bullish, driven by a powerful technical breakout where the ETF has reclaimed its 52-week highs and is trading well above both its 50-day and 200-day moving averages. This momentum is confirmed by aggressive options flow, with traders buying deep out-of-the-money calls to bet on a continuation of this trend. However, this short-term explosion masks a precarious long-term reality: the underlying business has suffered a severe multi-year collapse, dropping nearly 50% in the last two years alone. While the recent price action suggests a potential bottoming process or a sector-wide rotation, the fundamental trajectory remains deeply damaged, making this a high-risk, high-reward momentum play rather than a stable investment. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.080035 |
| AutoETS | 0.080531 |
| AutoARIMA | 0.080531 |
| AutoTheta | 0.089494 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 45% |
| H-stat | 2.59 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.048 |
| Excess Kurtosis | 0.69 |
As of July 11, 2026, 4:30 a.m. EDT: Speculators are aggressively positioning for a rally, evidenced by heavy call volume and open interest at strikes significantly above the current price (e.g., 50 and 55 strikes), while put activity remains sparse and concentrated only at lower strikes. Implied volatility is elevated on near-term calls, suggesting traders expect a sharp upward move or a 'long gamma' squeeze in the coming weeks.
| Last Yield | 1yr Yield | 3yr Avg | 5yr Avg |
|---|---|---|---|
| 1.63% | 1.63% | 1.00% | 0.60% |
| Date | Dividend | Yield % |
|---|---|---|
| 2025-12-22 | 0.655 | 1.630164 |
| 2024-12-20 | 0.240 | 0.986518 |
| 2023-12-20 | 0.082 | 0.368705 |
| 2017-12-20 | 0.297 | 1.084337 |
| 2015-12-21 | 0.147 | 0.504288 |
| Attribute | Value |
|---|---|
| All Time High | 62.6 |
| All Time Low | 13.42 |
| Ask | 51.36 |
| Ask Size | 300 |
| Average Daily Volume10 Day | 34,700 |
| Average Daily Volume3 Month | 27,001 |
| Average Volume | 27,001 |
| Average Volume10Days | 34,700 |
| Beta3 Year | 1.21 |
| Bid | 0.0 |
| Bid Size | 400 |
| Category | Health |
| Crypto Tradeable | 0 |
| Currency | USD |
| Custom Price Alert Confidence | HIGH |
| Day High | 52.18 |
| Day Low | 50.83 |
| Dividend Date | 1,514,332,800 |
| Dividend Yield | 1.24 |
| Esg Populated | 0 |
| Exchange | PCX |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 45.64226 |
| Fifty Day Average Change | 5.6977386 |
| Fifty Day Average Change Percent | 0.12483472 |
| Fifty Two Week Change Percent | 145.05646 |
| Fifty Two Week High | 54.95 |
| Fifty Two Week High Change | -3.6100006 |
| Fifty Two Week High Change Percent | -0.0656961 |
| Fifty Two Week Low | 20.87 |
| Fifty Two Week Low Change | 30.47 |
| Fifty Two Week Low Change Percent | 1.4599904 |
| Fifty Two Week Range | 20.87 - 54.95 |
| First Trade Date Milliseconds | 1,418,826,600,000 |
| Five Year Average Return | 0.019577 |
| Full Exchange Name | NYSEArca |
| Fund Family | Virtus |
| Fund Inception Date | 1,418,688,000 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Has Pre Post Market Data | 1 |
| Language | en-US |
| Legal Type | Exchange Traded Fund |
| Long Business Summary | Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval. |
| Long Name | Virtus LifeSci Biotech Clinical Trials ETF |
| Market | us_market |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_274653436 |
| Nav Price | 53.1663 |
| Net Assets | 52,678,624.0 |
| Net Expense Ratio | 0.65 |
| Open | 52.56 |
| Phone | (212) 593-4383 |
| Previous Close | 53.1648 |
| Price Hint | 2 |
| Quote Source Name | Delayed Quote |
| Quote Type | ETF |
| Region | US |
| Regular Market Change | -1.8248 |
| Regular Market Change Percent | -3.43234 |
| Regular Market Day High | 52.18 |
| Regular Market Day Low | 50.83 |
| Regular Market Day Range | 50.83 - 52.18 |
| Regular Market Open | 52.56 |
| Regular Market Previous Close | 53.1648 |
| Regular Market Price | 51.34 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 68,069 |
| Short Name | Virtus Biotech Clinical Trials |
| Source Interval | 15 |
| Symbol | BBC |
| Three Year Average Return | 0.2890296 |
| Total Assets | 52,678,624 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Peg Ratio | None |
| Trailing Three Month Nav Returns | 26.28685 |
| Trailing Three Month Returns | 26.28685 |
| Triggerable | 1 |
| Two Hundred Day Average | 39.836933 |
| Two Hundred Day Average Change | 11.503067 |
| Two Hundred Day Average Change Percent | 0.28875384 |
| Type Disp | ETF |
| Volume | 68,069 |
| Yield | 0.0124 |
| Ytd Return | 36.18484 |